Clinical Trial Update: Risk Reduction for Alzheimer's Disease [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial update on risk reduction for Alzheimer's disease in cognitively normal older adults, including those with hypertension, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment
• Hypertension

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Cognitively Normal Older Adults, Hypertension | Phase 2, Phase 3 | Status: COMPLETED